- Home
- Publications
- Publication Search
- Publication Details
Title
Diabetic Kidney Disease: Pathophysiology and Therapeutic Targets
Authors
Keywords
-
Journal
Journal of Diabetes Research
Volume 2015, Issue -, Pages 1-16
Publisher
Hindawi Limited
Online
2015-05-01
DOI
10.1155/2015/697010
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Diabetic kidney disease: a clinical update from Kidney Disease: Improving Global Outcomes
- (2015) Mark E. Molitch et al. KIDNEY INTERNATIONAL
- Updating the natural history of diabetic nephropathy
- (2014) Giuseppe Pugliese ACTA DIABETOLOGICA
- Novel Therapies for Diabetic Kidney Disease
- (2014) Radica Z. Alicic et al. ADVANCES IN CHRONIC KIDNEY DISEASE
- Sodium/Glucose Cotransporter 2 Inhibitors and Prevention of Diabetic Nephropathy: Targeting the Renal Tubule in Diabetes
- (2014) Luca De Nicola et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Predictors of Congestive Heart Failure after Treatment with an Endothelin Receptor Antagonist
- (2014) J. Hoekman et al. Clinical Journal of the American Society of Nephrology
- Role of Heparanase-Driven Inflammatory Cascade in Pathogenesis of Diabetic Nephropathy
- (2014) R. Goldberg et al. DIABETES
- Efficacy and safety of canagliflozin over 52 weeks in patients with type 2 diabetes mellitus and chronic kidney disease
- (2014) J.-F. Yale et al. DIABETES OBESITY & METABOLISM
- Molecular mechanisms of diabetic kidney disease
- (2014) Kimberly Reidy et al. JOURNAL OF CLINICAL INVESTIGATION
- Nitric oxide in the normal kidney and in patients with diabetic nephropathy
- (2014) Paolo Tessari JOURNAL OF NEPHROLOGY
- Sweet Debate: Fructose versus Glucose in Diabetic Kidney Disease
- (2014) P. Beckerman et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- The Endothelin Antagonist Atrasentan Lowers Residual Albuminuria in Patients with Type 2 Diabetic Nephropathy
- (2014) D. de Zeeuw et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Endogenous Fructose Production and Fructokinase Activation Mediate Renal Injury in Diabetic Nephropathy
- (2014) M. A. Lanaspa et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Novel targets of antifibrotic and anti-inflammatory treatment in CKD
- (2014) Anne-Emilie Declèves et al. Nature Reviews Nephrology
- Sodium-glucose cotransport inhibitors: mechanisms, metabolic effects and implications for the treatment of diabetic patients with chronic kidney disease: FIGURE 1:
- (2014) George Vlotides et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Sirtuin-3 (SIRT3), a therapeutic target with oncogenic and tumor-suppressive function in cancer
- (2014) Y Chen et al. Cell Death & Disease
- Molecular Mechanisms of Diabetic Retinopathy, General Preventive Strategies, and Novel Therapeutic Targets
- (2014) Sher Zaman Safi et al. Biomed Research International
- Long-Term Efficacy of Dapagliflozin in Patients With Type 2 Diabetes Mellitus Receiving High Doses of Insulin
- (2013) John P.H. Wilding ANNALS OF INTERNAL MEDICINE
- Role of Nrf2 in Oxidative Stress and Toxicity
- (2013) Qiang Ma Annual Review of Pharmacology and Toxicology
- Anti-aging molecule, Sirt1: a novel therapeutic target for diabetic nephropathy
- (2013) Shinji Kume et al. ARCHIVES OF PHARMACAL RESEARCH
- The Modern Spectrum of Renal Biopsy Findings in Patients with Diabetes
- (2013) S. G. Sharma et al. Clinical Journal of the American Society of Nephrology
- Short-Term Changes after a Weight Reduction Intervention in Advanced Diabetic Nephropathy
- (2013) A. N. Friedman et al. Clinical Journal of the American Society of Nephrology
- Obesity-Mediated Autophagy Insufficiency Exacerbates Proteinuria-induced Tubulointerstitial Lesions
- (2013) K. Yamahara et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Intensive glucose control improves kidney outcomes in patients with type 2 diabetes
- (2013) Vlado Perkovic et al. KIDNEY INTERNATIONAL
- Long-term study of patients with type 2 diabetes and moderate renal impairment shows that dapagliflozin reduces weight and blood pressure but does not improve glycemic control
- (2013) Donald E. Kohan et al. KIDNEY INTERNATIONAL
- Efficacy and safety of canagliflozin versus glimepiride in patients with type 2 diabetes inadequately controlled with metformin (CANTATA-SU): 52 week results from a randomised, double-blind, phase 3 non-inferiority trial
- (2013) William T Cefalu et al. LANCET
- Epidemiology of Diabetic Kidney Disease
- (2013) Anne T. Reutens MEDICAL CLINICS OF NORTH AMERICA
- Bardoxolone Methyl in Type 2 Diabetes and Stage 4 Chronic Kidney Disease
- (2013) Dick de Zeeuw et al. NEW ENGLAND JOURNAL OF MEDICINE
- Autophagy Attenuates Diabetic Glomerular Damage through Protection of Hyperglycemia-Induced Podocyte Injury
- (2013) Li Fang et al. PLoS One
- Autophagy: Emerging Therapeutic Target for Diabetic Nephropathy
- (2013) Shinji Kume et al. SEMINARS IN NEPHROLOGY
- Effect of Addition of Silymarin to Renin-Angiotensin System Inhibitors on Proteinuria in Type 2 Diabetic Patients With Overt Nephropathy: A Randomized, Double-Blind, Placebo-Controlled Trial
- (2012) Mohammad Kazem Fallahzadeh et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Effects of Sevelamer on HbA1c, Inflammation, and Advanced Glycation End Products in Diabetic Kidney Disease
- (2012) H. Vlassara et al. Clinical Journal of the American Society of Nephrology
- Effect of Thiazolidinedione Treatment on Proteinuria and Renal Hemodynamic in Type 2 Diabetic Patients with Overt Nephropathy
- (2012) F. Pistrosch et al. HORMONE AND METABOLIC RESEARCH
- A new mechanism of action of sulodexide in diabetic nephropathy: inhibits heparanase-1 and prevents FGF-2-induced renal epithelial-mesenchymal transition
- (2012) Valentina Masola et al. Journal of Translational Medicine
- Oral Supplementation with Cholecalciferol 800 IU Ameliorates Albuminuria in Chinese Type 2 Diabetic Patients with Nephropathy
- (2012) Yan Huang et al. PLoS One
- VEGF and Podocytes in Diabetic Nephropathy
- (2012) Alda Tufro et al. SEMINARS IN NEPHROLOGY
- Sulodexide for Kidney Protection in Type 2 Diabetes Patients With Microalbuminuria: A Randomized Controlled Trial
- (2011) Edmund J. Lewis et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Autophagy regulates inflammation in adipocytes
- (2011) Takeshi Yoshizaki et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Resveratrol protects diabetic kidney by attenuating hyperglycemia-mediated oxidative stress and renal inflammatory cytokines via Nrf2–Keap1 signaling
- (2011) P. Palsamy et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Resveratrol Improves Oxidative Stress and Protects Against Diabetic Nephropathy Through Normalization of Mn-SOD Dysfunction in AMPK/SIRT1-Independent Pathway
- (2011) M. Kitada et al. DIABETES
- Heparanase Is Essential for the Development of Diabetic Nephropathy in Mice
- (2011) N. Gil et al. DIABETES
- Dietary Restriction Ameliorates Diabetic Nephropathy through Anti-Inflammatory Effects and Regulation of the Autophagy via Restoration of Sirt1 in Diabetic Wistar Fatty (fa/fa) Rats: A Model of Type 2 Diabetes
- (2011) Munehiro Kitada et al. Experimental Diabetes Research
- Pyridorin in Type 2 Diabetic Nephropathy
- (2011) E. J. Lewis et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Sulodexide Fails to Demonstrate Renoprotection in Overt Type 2 Diabetic Nephropathy
- (2011) D. K. Packham et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Pirfenidone for Diabetic Nephropathy
- (2011) K. Sharma et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Bardoxolone Methyl and Kidney Function in CKD with Type 2 Diabetes
- (2011) Pablo E. Pergola et al. NEW ENGLAND JOURNAL OF MEDICINE
- Oral supplementation of turmeric attenuates proteinuria, transforming growth factor-β and interleukin-8 levels in patients with overt type 2 diabetic nephropathy: A randomized, double-blind and placebo-controlled study
- (2011) Parviz Khajehdehi et al. SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY
- Cilostazol Ameliorates Nephropathy in Type 1 Diabetic Rats Involving Improvement in Oxidative Stress and Regulation of TGF-β and NF-κB
- (2010) Wen-Chin LEE et al. BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY
- Phase 1 Study of Anti-CTGF Monoclonal Antibody in Patients with Diabetes and Microalbuminuria
- (2010) S. G. Adler et al. Clinical Journal of the American Society of Nephrology
- A Double-Blind, Randomized, Placebo-Controlled Clinical Trial on Benfotiamine Treatment in Patients With Diabetic Nephropathy
- (2010) A. Alkhalaf et al. DIABETES CARE
- NF- B in Renal Inflammation
- (2010) A. B. Sanz et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Suppressors of Cytokine Signaling Abrogate Diabetic Nephropathy
- (2010) G. Ortiz-Munoz et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Avosentan for Overt Diabetic Nephropathy
- (2010) J. F.E. Mann et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- JAK/STAT signaling in renal diseases
- (2010) Peter Y. Chuang et al. KIDNEY INTERNATIONAL
- Autophagy and the Integrated Stress Response
- (2010) Guido Kroemer et al. MOLECULAR CELL
- The multifaceted therapeutic potential of benfotiamine
- (2010) Pitchai Balakumar et al. PHARMACOLOGICAL RESEARCH
- Captopril and Combination Therapy of Captopril and Pentoxifylline in Reducing Proteinuria in Diabetic Nephropathy
- (2010) Jamshid Roozbeh et al. RENAL FAILURE
- The hexosamine biosynthesis inhibitor azaserine prevents endothelial inflammation and dysfunction under hyperglycemic condition through antioxidant effects
- (2009) Angana Gupta Rajapakse et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Dapagliflozin for the Treatment of Type 2 Diabetes
- (2009) Amie McCord Brooks et al. ANNALS OF PHARMACOTHERAPY
- Nonalbuminuric Renal Impairment in Type 2 Diabetic Patients and in the General Population (National Evaluation of the Frequency of Renal Impairment cO-existing with NIDDM [NEFRON] 11)
- (2009) M. C. Thomas et al. DIABETES CARE
- The endothelin receptor antagonist avosentan ameliorates nephropathy and atherosclerosis in diabetic apolipoprotein E knockout mice
- (2009) A. M. D. Watson et al. DIABETOLOGIA
- Pirfenidone Is Renoprotective in Diabetic Kidney Disease
- (2009) S. P. RamachandraRao et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Autophagy regulates lipid metabolism
- (2009) Rajat Singh et al. NATURE
- Connective tissue growth factor(CCN2), a pathogenic factor in diabetic nephropathy. What does it do? How does it do it?
- (2009) Roger M. Mason Journal of Cell Communication and Signaling
- The Effect of Pentoxifylline on Proteinuria in Diabetic Kidney Disease: A Meta-analysis
- (2008) Brendan B. McCormick et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- The Natural Course of Microalbuminuria among African Americans with Type 2 Diabetes: A 3-Year Study
- (2008) Mohamed G. Atta et al. AMERICAN JOURNAL OF MEDICINE
- Rhein reverses the diabetic phenotype of mesangial cells over-expressing the glucose transporter (GLUT1) by inhibiting the hexosamine pathway
- (2008) J-M Zheng et al. BRITISH JOURNAL OF PHARMACOLOGY
- Role of AGEs in Diabetic Nephropathy
- (2008) Kei Fukami et al. CURRENT PHARMACEUTICAL DESIGN
- Enhanced Expression of Janus Kinase-Signal Transducer and Activator of Transcription Pathway Members in Human Diabetic Nephropathy
- (2008) C. C. Berthier et al. DIABETES
- Abnormal Glomerular Permeability Characteristics in Diabetic Nephropathy: Implications for the therapeutic use of low-molecular weight heparin
- (2008) E. J. Lewis et al. DIABETES CARE
- Sodium-Glucose Cotransport Inhibition With Dapagliflozin in Type 2 Diabetes
- (2008) J. F. List et al. DIABETES CARE
- Role of reactive oxygen species in the pathogenesis of diabetic nephropathy
- (2008) Hunjoo Ha et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- The kidney in diabetes: dynamic pathways of injury and repair. The Camillo Golgi Lecture 2007
- (2008) P. Fioretto et al. DIABETOLOGIA
- The Role of Inflammatory Cytokines in Diabetic Nephropathy
- (2008) J. F. Navarro-Gonzalez et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Ameliorative effect of combination of benfotiamine and fenofibrate in diabetes-induced vascular endothelial dysfunction and nephropathy in the rat
- (2008) Pitchai Balakumar et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes
- (2008) NEW ENGLAND JOURNAL OF MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started